Proteolysis-Targeting Chimera (PROTAC): Is the Technology Looking at the Treatment of Brain Tumors?

Lospinoso Severini, Ludovica; Bufalieri, Francesca; Infante, Paola; Di Marcotullio, Lucia

Lospinoso Severini, Ludovica; Bufalieri, Francesca; Infante, Paola; Di Marcotullio, Lucia.

Afiliación

Lospinoso Severini L; Department of Molecular Medicine, University of Rome La Sapienza, Rome, Italy.
Bufalieri F; Department of Molecular Medicine, University of Rome La Sapienza, Rome, Italy.
Infante P; Department of Molecular Medicine, University of Rome La Sapienza, Rome, Italy.
Di Marcotullio L; Department of Molecular Medicine, University of Rome La Sapienza, Rome, Italy.

Front Cell Dev Biol ; 10: 854352, 2022.

Article en En | MEDLINE | ID: mdl-35242765

Palabras clave

cancer; cancer therapy; glioblastoma; protac (proteolysis targeting chimera); ubiquitylation (ubiquitination)

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Cell Dev Biol Año: 2022 Tipo del documento: Article País de afiliación: Italia